Dietary glycemic index during pregnancy is associated with biomarkers of the metabolic syndrome in offspring at age 20 years. by Danielsen, Inge et al.
Dietary Glycemic Index during Pregnancy Is Associated
with Biomarkers of the Metabolic Syndrome in Offspring
at Age 20 Years
Inge Danielsen1*, Charlotta Granstro¨m1, Thorhallur Haldorsson1,2, Dorte Rytter3, Bodil Hammer Bech3,
Tine Brink Henriksen4, Allan Arthur Vaag5,6, Sjurdur Frodi Olsen1
1Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark, 2 The Unit for Nutrition Research, Faculty of
Food Science and Nutrition, School of Health Sciences, University of Iceland, Reykjavik, Iceland, 3Centre for Fetal Programming, Department of Public Health, Section for
Epidemiology, Aarhus University, Aarhus, Denmark, 4Department of Paediatrics, Aarhus University Hospital, Skejby, Denmark, 5Department of Endocrinology,
Rigshospitalet, Copenhagen, Denmark, 6Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Abstract
Objective: Growing evidence indicates that metabolic syndrome is rooted in fetal life with a potential key role of nutrition
during pregnancy. The objective of the study was to assess the possible associations between the dietary glycemic index
(GI) and glycemic load (GL) during pregnancy and biomarkers of the metabolic syndrome in young adult offspring.
Methods: Dietary GI and GL were assessed by questionnaires and interviews in gestation week 30 and offspring were
clinically examined at the age of 20 years. Analyses based on 428 mother-offspring dyads were adjusted for maternal
smoking during pregnancy, height, pre-pregnancy body mass index (BMI), education, energy intake, and the offspring’s
ambient level of physical activity. In addition, possible confounding by gestational diabetes mellitus was taken into account.
Outcome Measures: Waist circumference, blood pressure, HOMA insulin resistance (HOMA-IR) and plasma levels of fasting
glucose, triglycerides, HDL cholesterol, LDL cholesterol, total cholesterol, insulin, and leptin were measured in the offspring.
Results: Significant associations were found between dietary GI in pregnancy and HOMA-IR (the relative increase in HOMA-
IR per 10 units’ GI increase was 1.09 [95% CI: 1.01, 1.16], p = 0.02), insulin (1.09 [95% CI: 1.02, 1.16], p = 0.01) and leptin (1.21
[95% CI: 1.06, 1.38], p = 0.01) in the offspring; whereas no associations were detected for GL.
Conclusions: Our data suggests that high dietary GI in pregnancy may affect levels of markers for the metabolic syndrome
in young adult offspring in a potentially harmful direction.
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Introduction
Metabolic diseases, including the metabolic syndrome (MS),
have been on the rise worldwide during the last two decades. MS is
associated with increased risk of cardiovascular disease and type 2
diabetes and consists of the components: central obesity, reduced
HDL cholesterol and raised triglyceride levels, as well as raised
blood pressure and fasting plasma glucose levels [1]. Growing
evidence indicates that MS is rooted in fetal life with a potential
key role of nutrition during pregnancy [2]. The intrauterine
environment, influenced by the maternal diet, may ‘‘programme’’
the fetus and thus influence susceptibility for MS in later life [3,4].
The composition and amount of carbohydrates consumed
during pregnancy are of particular interest. Dietary GI is a
measure of the postprandial effect on the plasma glucose of the
carbohydrate of a food item compared to the effect of the same
amount of carbohydrate in pure glucose or white bread. GL in
addition takes into account the amount of carbohydrate in the
food item and thus is a more quantitative measure [5]. The
concept of GI was first introduced by Jenkins et al. in 1981 [6] and
is a commonly used measure of carbohydrate quality. Evidence
has emerged from human and animal studies that maternal
glucose levels may be predictive of metabolic disorders in the
offspring [7–9]. Among a group of non-diabetic and generally
healthy pregnant women, it has been shown that dietary GI is
associated with the levels of glycosylated hemoglobin and plasma
glucose [10]. There is also some evidence to support that a low GI
diet during pregnancy may improve fetal glucose and insulin
regulation and reduce birth weight and fetal adiposity [2,10–13],
although not all studies have supported this [14]. We are unaware
of any previous studies in humans investigating the association
between dietary GI or GL during pregnancy and the metabolic
profile in the adult offspring. Accordingly, this association was
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studied in a unique prospective birth cohort with 20 years’ follow-
up.
Materials and Methods
Ethics Statement
The study was approved by the Danish Data Protection Agency
and the Central Denmark Region Committees on Biomedical
Research Ethics (Reference No. 20070157). Written consent was
obtained from all participants.
The Danish Fetal Origin Cohort 1988
In 1988 a total of 965 out of 1212 eligible women with singleton
pregnancies were recruited for a birth cohort study in Denmark
[15]. Prior to the routine antenatal visit in gestational week 30, the
pregnant women received a postal questionnaire to complete and
return to the antenatal care clinic. Following the antenatal visit, a
15-minute face-to-face interview was conducted by a trained
person who corroborated the response to the self-administered
questionnaire and completed a second interviewer-guided ques-
tionnaire with the women. The two questionnaires covered
medical history, diet and other lifestyle as well as socio-economic
factors. Further information about the women’s health, birth
outcomes, medical history, and anthropometry was extracted from
hospital records and from the Danish Medical Birth Registry as
well as from the records kept by the midwives and general
practitioners. Moreover, screening for gestational diabetes mellitus
(GDM) was done with fasting glucose measurements in woman
who were obese, had a family history of diabetes mellitus, GDM in
a previous pregnancy, a previous delivery of an infant above
4500 g, previous stillbirth, age above 38 years, or glucosuria in the
current pregnancy. When two independent fasting capillary
plasma glucose values were above 4.6 mmol/L the woman was
referred to an OGTT [16].
Offspring Follow Up
During 2008 and 2009, mothers and offspring were contacted
and offspring invited to complete a web-based questionnaire
including inquiries on current health, lifestyle and dietary habits as
well as height, weight and waist circumference.
All potential participants were asked to participate in a clinical
examination. The participants were examined between 8:00 AM
and 12:30 PM after an overnight fasting. Height, weight and waist
circumference were measured. After 7 min. of rest, blood pressure
was measured three times in the horizontal position (2 min.
intervals in between) using an automatic blood pressure device
(OMRON M6 Comfort HEM-7000-E). The average value of the
last two measurements was used in the analyses. A venous blood
sample was drawn and immediately centrifuged and frozen at
280uC.
From a total number of 965 women we traced 894 singleton
offspring. The remaining study group included twins, mothers and
children with an incorrect personal identification number (in use
for every citizen in Denmark), stillbirths, mothers and children
who had died or were abroad, or with unknown addresses, or
offspring that was unable to participate because of illness.
A total of 688 subjects (77% of the eligible population)
participated in the follow up study by filling out the questionnaire,
providing information on the offspring’s level of physical activity,
and of these 439 attended the clinical examination.
Offspring Biomarkers
Plasma glucose levels were measured using bedside equipment
(Accu-chek, Roche Diagnostics, Germany) immediately after
blood sampling. Serum leptin concentrations were determined at
the Medical Research Laboratories, Aarhus University Hospital,
Denmark, by a time-resolved immunofluorometric assay based on
commercially available reagents and recombinant human leptin as
standard [17]. Plasma insulin concentrations were determined
using a commercial ELISA kit. Insulin resistance was estimated
using the homeostasis model assessment for insulin resistance
(HOMA-IR) by means of the formula: fasting glucose (mmol/L) x
fasting insulin (mU/L)/22.5 [18]. Serum triglycerides and
cholesterol fractions (total cholesterol, LDL, HDL) were measured
according to standard methods on a Modular P from Roche
Diagnostics, Basel, Switzerland.
Markers for MS
Primary outcome variables were chosen among the continuous
variables inherent in the definition of MS, i.e. waist circumference
(cm), fasting levels of plasma glucose (mmol/L), triglycerides
(mmol/L) and HDL cholesterol (mmol/L), as well as systolic and
diastolic blood pressure measurements (mmHg). Additionally, the
primary outcome variables were supplemented with secondary
variables associated with MS including BMI (kg/m2), plasma levels
of LDL and total cholesterol (mmol/L), concentrations of fasting
plasma insulin (pmol/L) and leptin (ug/L), as well as HOMA-IR.
Waist circumference and BMI were determined solely by means of
data from the clinical examinations (439 subjects) to eliminate the
possibility of under-reported data on BMI and waist circumfer-
ence. BMI.18.5 and ,25 kg/m2 was considered normal,
whereas BMI#18.5, BMI$25.0 kg/m2 and BMI$30.0 kg/m2 is
termed underweight, overweight and obese, respectively.
Exposure Variables
The dietary assessment method used was a self-administered
semi-quantitative food questionnaire combined with an interview
in which photographic aids were used to assess portion sizes. The
women were systematically asked about all possible categories of
food items. The questions gave information on how often per week
or per day the food item was consumed and how much per
portion. Assessment of dietary intake was done by means of a
national food composition database using standard recipes and
standard portion sizes supplementing the answers from the
questionnaire.
Dietary GI is a measure of the increase in plasma glucose after
intake of a food item (containing 50 or 100 g of carbohydrate) and
defined as the incremental area under the postprandial glucose
response curve in percentage of the corresponding area following
intake of a standard reference food item (same amount of
carbohydrate), which can be either glucose or white bread [5].
Thus, GI measures the effect of the carbohydrate in the specific
food item on the plasma glucose and thus represents a quality
aspect of the food. GL represents both the quality and the quantity
of the food, taking into account that the glycemic effect of a food
item depends not only on the GI but also on the amount of
carbohydrate eaten. Application of GI and GL in research and
partly in clinical settings is widespread though the concept of GI is
still contentious because of controversies relating to methodology
and clinical applicability [19,20].
For foods included in the questionnaire, we used the GI-table
from Foster-Powell et al. 2002 [5], though a newer table exists
[21], with white bread as the standard reference. The table
contains GI-values measured during a time period close to the
time when the dietary data were collected in the cohort. This is
important as the composition of processed foods, and thereby the
GI of these food items, changes over time. Daily dietary GI was
calculated as the product of the GI and carbohydrate content for
GI in Pregnancy and MS Markers in the Offspring
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each food or beverage, summed for all items consumed either as a
snack or as part of a meal in average per day and divided by the
total carbohydrate intake per day. Daily GL was calculated as the
product of the GI and carbohydrate content for each food or
beverage and summed for all items consumed in average per day
and then energy-adjusted by the residual method [22]. Both
variables were analysed as continuous variables and in quintiles
based on the diet of all women in the cohort (n = 894).
Statistical Analyses
Baseline characteristics of pregnant women either with partic-
ipating or non-participating offspring were tested for differences by
x2-test. Distributions of covariates according to maternal exposure
of GI and GL were tested for trends across quintiles of GI and GL
by using Mantel-Haentzel x2-test for trend for categorical
covariates. Associations between maternal GI and GL and
offspring outcome variables were examined by multivariate linear
regression analyses. Waist circumference was adjusted for BMI
using the residual method [23], providing an uncorrelated
measure of BMI and waist circumference. Due to skewed
distributions, all outcome variables except adjusted waist circum-
ference and blood pressure were log-transformed. We a priori
decided to include the following covariates: maternal height
(continuous, 3% missing), education (five categories, 5% missing),
smoking (yes or no, 5% missing), pre-pregnancy BMI (continuous,
3% missing), energy intake (five quintiles, 0% missing), and
offspring’s current physical activity (four categories, 0% missing).
Observations with missing covariate values were excluded from
the analyses.
Maternal height, pre-pregnancy BMI and offspring’s physical
activity were included as these variables are possible determinants
of anthropometric and metabolic measures in the offspring.
Energy intake was included as it is associated with the diet and
possibly also the outcome variables. Maternal education and
smoking were included to account for potential social and lifestyle
confounding. In the presented data, women diagnosed with GDM
were excluded from the analyses. Furthermore, the influence of
GDM status was investigated by conducting the analyses after
inclusion of the GDM cases.
The analyses were performed for combined sexes as well as
males and females separately. The combined analysis included sex
in the model along with the other covariates. Among the women
with participating offspring, the GI varied between 49.3 and 88.3,
whereas GL varied between 108.6 and 267.6. Considering this
exposure range, analyses were made using exposures of 10 units’
increments with the aim to create results with magnitudes of
clinical relevance. Mean changes in outcome variables for 10 units’
increment in GI and GL are presented as absolute increments for
waist circumference and blood pressure and relative increments
for BMI and offspring biomarkers. These measures of association
are expressed as ‘difference per 10U GI/GL increase’ and ‘ratio
per 10U GI/GL increase’. Associations were considered statisti-
cally significant at the 5% level and all regression coefficients are
presented with 95% CI. All analyses were performed using the
SAS GLM procedure (Version 9.3; SAS Institute, Cary, NC).
Results
Mothers of participating offspring were more often normal
weight and non-smokers and had a higher education compared to
mothers of non-participating offspring (table 1). Furthermore they
had a higher energy intake. No significant differences were
observed between the two groups regarding dietary GI and GL.
There was a significant association between increasing GI and
GL and decreasing education, and fewer women with a low GL
intake were smoking compared to women with at high GL intake
(supplementary table S1). No significant association was found
with any other covariate included in the model.
Of the 439 women included in the analyses, 121 women with
high risk of GDM were screened and 11 (9.0% of the screened
group and 2.5% of the total group) were diagnosed. The estimated
prevalence of GDM in Denmark in 1999–2000 was 2.4% [24],
corresponding to between 10 and 11 GDM cases in a population
of 439 women. The 11 GDM cases were excluded from the
analyses reported in tables 2–4. For unadjusted results, please see
the supplementary tables S2, S3, and S4.
In the adjusted analyses of offspring of both sexes (table 2), we
found no associations among the primary outcome variables.
Among the secondary variables, with increasing GI we found
higher levels of total cholesterol (ratio per 10U GI increase 1.03
(95% CI: 1.00, 1.06)), higher HOMA-IR (ratio 1.09 (95% CI:
1.01, 1.16)), and higher levels of insulin (ratio 1.09 (95% CI: 1.02,
1.16)) and leptin (ratio 1.21 (95% CI: 1.06, 1.38)). Analyses with
quintiles of GI did not consistently result in significant associations
but were generally in agreement with the analyses with the
continuous variable. No associations were observed for GL (data
not shown).
In female offspring exposed to maternal GI (table 3) we found
no associations among the primary outcome variables. Among the
secondary variables, with increasing GI we found higher levels of
total cholesterol (ratio 1.05 (95% CI: 1.01, 1.09)) and leptin (ratio
1.21 (95% CI: 1.05, 1.40)) and in addition a borderline significant
association with higher levels of insulin (ratio 1.08 (95% CI: 0.99,
1.19)). Furthermore, with increasing GL the data showed
significant associations with the primary variables: systolic blood
pressure (difference per 10U GL increase 20.46 (95% CI: 20.91,
20.01)) and waist circumference (difference 0.26 (95% CI: 0.01,
0.51).
No significant associations between maternal GI and GL and
any outcome measure were observed in male offspring (table 4 and
data not shown).
Inclusion of the 11 GDM cases in the analyses did not change
the associations (data not shown). Adding the offspring’s waist
circumference to the statistical model did not the change the
associations either (data not shown).
Discussion
In this study we showed significant associations between high
dietary GI in pregnancy and key markers of the metabolic
syndrome (MS) in the young adult offspring. The results may be of
clinical relevance. Thus, an increase in maternal GI of 10 units
was associated with increased HOMA-IR, as well as increased
levels of insulin and leptin among offspring of 9, 9 and 21%,
respectively.
GL was not associated with MS markers among the offspring in
the combined analyses. Nevertheless, among the females the
observed association between increasing GL and higher waist
circumference could be clinically relevant, as the possible effect of
an increase of only 10 GL units – out of a total exposure range of
159 GL units - was 0.3 cm. A borderline significant association
between increasing GL and lower systolic blood pressure among
female offspring only. The extent to which these associations may
be of clinical relevance remains to be determined.
Additional adjustment for the offspring’s waist circumference
did not change the associations between GI in pregnancy and MS
markers in the offspring, suggesting that factors other than current
GI in Pregnancy and MS Markers in the Offspring
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abdominal adiposity and body composition may explain the
associations. These results are in full agreement with a recent study
reporting that carbohydrate-rich diet supplementation in pregnant
rats was associated with increased insulin, leptin and glucose levels
among their adult male offspring, while no association was found
with the offspring’s body weight [25]. These results in rats together
with ours in humans support the idea that GI (and perhaps GL)
during pregnancy may exhibit a causal programming effect in the
adult offspring. Nevertheless, in our observational study we cannot
exclude the theoretical possibility that mother’s and child’s
lifestyles, including eating and physical activity habits, even after
20 years, may be similar as a result of social and familial factors.
However, excluding the offspring’s physical activity from the
statistical model did not change the associations between maternal
GI and offspring MS markers (data not shown). The extent to
which the mother’s diet during pregnancy is associated with the
diet and eating habits of the offspring is unknown. Nevertheless,
leptin in the offspring, the level of which was associated with the
mother’s GI, may influence upon appetite and eating patterns
[26]. Accordingly, it is possible that the offspring’s diet and levels
of leptin may act in concert as mediators in the pathways between
maternal GI and offspring MS markers. In this perspective it
would be incorrect to adjust for the offspring’s diet.
Epigenetic mechanisms may be involved in developmental
programming of MS by GI in pregnancy. Thus, a recent study
found associations between maternal carbohydrate content in
early pregnancy and DNA methylation of candidate genes from
umbilical cord tissue and between the methylation status at birth
and child’s obesity at the age of 9 [27].
According to the ‘‘Pedersen hypothesis’’ and the theory of ‘‘fuel
mediated teratogenesis’’, maternal glucose crosses the placenta
and results in intrauterine hyperglycemia and fetal hyperinsulin-
emia leading to increased fetal growth and adiposity with
consequences for later health [28–30]. This may explain the right
side of the U-shaped association between birth weight and
subsequent development of type 2 diabetes [31,32]. Interestingly,
Table 1. Characteristics of 894 pregnant women in the birth cohort dependent on their offspring’s participation in the follow up.
Mothers with non-participating
offspring (n =206)
Mothers with participating
offspring (n =688)
Percent Percent p-value
Height 0.73
2159 9 8
160–164 24 20
165–169 33 34
170–174 23 26
175- 11 13
Education ,0.0001
None 22 13
Vocational 36 23
Bachelor 35 44
Academic 6 19
BMI (kg/m2) ,0.01
,18.6 15 9
18.6–,25 72 82
25–,30 8 6
30– 5 2
Smoking in pregnancy 50 37 ,0.001
Nulliparous 56 59 0.46
Energy intake 0.03
Lowest quintile 24 19
Mid quintile 15 22
Highest quintile 17 21
Glycemic Index 0.98
Lowest quintile 20 20
Mid quintile 21 20
Highest quintile 20 20
Glycemic Load 0.07
Lowest quintile 24 19
Mid quintile 21 20
Highest quintile 23 19
Differences between the two groups of women are reported as p-value from x2-test for measure of association.
doi:10.1371/journal.pone.0064887.t001
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Table 2. MS markers in male and female offspring dependent on their mothers’ dietary GI in 2nd trimester.
Ratio or difference* (95% CI)
GI quintile 1 GI quintile 2 GI quintile 3 GI quintile 4 GI quintile 5 GI continuous p-value
Mean 6 SD 60.8+3.6 67.4+1.3 71.1+1.0 74.5+1.1 80.0+2.7 70.566.9
Fasting glucose 4.9 mmol/L (61.1) 1 0.99 (0.97, 1.01) 1.01 (0.99, 1.04) 1.03 (1.00, 1.05) 1.00 (0.98, 1.03) 1.01 (1.00, 1.02) 0.18
Triglycerides 0.9 mmol/L (61.5) 1 1.04 (0.91, 1.18) 1.10 (0.97, 1.24) 1.16 (1.02, 1.32) 1.04 (0.90, 1.19) 1.04 (0.98, 1.11) 0.18
HDL cholesterol 1.4 mmol/L (61.2) 1 1.05 (0.98, 1.12) 1.04 (0.98, 1.11) 1.05 (0.98, 1.12) 1.03 (0.96, 1.11) 1.03 (1.00, 1.06) 0.09
LDL cholesterol 2.4 mmol/L (61.3) 1 1.05 (0.96, 1.15) 1.07 (0.98, 1.16) 1.10 (1.01, 1.21) 1.07 (0.97, 1.18) 1.03 (0.98, 1.08) 0.26
Total cholesterol 4.3 mmol/L (61.2) 1 1.04 (0.98, 1.10) 1.06 (1.00, 1.12) 1.09 (1.03, 1.15) 1.05 (0.99, 1.12) 1.03 (1.00, 1.06) 0.05
Systolic blood
pressure*
109.9 mmHg (610.6) 0 22.58
(25.27, 0.10)
21.31
(23.93, 1.30)
20.10
(22.84, 2.63)
22.11
(25.02, 0.81)
20.55
(21.91, 0.82)
0.43
Diastolic blood
pressure*
65.7 mmHg (66.7) 0 20.21
(22.25, 1.83)
0.33
(21.66, 2.31)
1.15
(20.92, 3.22)
20.25
(22.46, 1.95)
0.29
(20.74, 1.32)
0.59
Waist
circumference*
81.6 cm (66.0) 0 0.28
(21.08, 1.65)
0.32
(21.01, 1.64)
0.71
(20.68, 2.10)
1.14
(20.34, 2.62)
0.47
(20.22, 1.16)
0.18
BMI 22.2 kg/m2 (61.1) 1 0.99 (0.95, 1.03) 1.02 (0.98, 1.06) 1.03 (0.99, 1.08) 1.01 (0.97, 1.05) 1.01 (0.99, 1.03) 0.28
HOMA-IR 1.2 (61.6) 1 1.04 (0.91, 1.19) 1.16 (1.01, 1.32) 1.27 (1.11, 1.46) 1.11 (0.96, 1.28) 1.09 (1.01, 1.16) 0.02
Insulin 39.5 pmol/L (61.5) 1 1.08 (0.94, 1.23) 1.15 (1.01, 1.30) 1.26 (1.11, 1.44) 1.12 (0.97, 1.29) 1.09 (1.02, 1.16) 0.01
Leptin 6.7 ug/L (63.3) 1 0.93 (0.72, 1.21) 1.22 (0.95, 1.57) 1.38 (1.06, 1.79) 1.21 (0.91, 1.60) 1.21 (1.06, 1.38) 0.01
Shown are the mean differences in the outcome variables waist circumference and systolic and diastolic blood pressure (indicated by*) and mean ratio for all other log
transformed outcome variables. The table includes figures from analyses of quintiles of GI, and from analyses of the data using GI as continuous variable (ratio or
difference per 10U GI increment)1.
1Adjustment for potential confounding by multiple linear regression including energy intake, pre-pregnancy BMI (kg/m2), height (cm), smoking, education, and
offspring sex and leisure activity. The p-value is the result of analyses of the data using GI as continuous variable (n = 386). GI quintiles were determined from the
original data files including 894 women.
doi:10.1371/journal.pone.0064887.t002
Table 3. MS markers in female offspring dependent on their mothers’ dietary GI in 2nd trimester.
Ratio or difference* (95% CI)
GI quintile
1 GI quintile 2 GI quintile 3 GI quintile 4 GI quintile 5 GI continuous p-value
Mean 6 SD 60.8+3.6 67.4+1.3 71.1+1.0 74.5+1.1 80.0+2.7 70.4+6.7
Fasting glucose 4.8 mmol/L (61.1) 1 0.98 (0.95, 1.02) 1.01 (0.98, 1.05) 1.02 (0.99, 1.06) 0.99 (0.96, 1.03) 1.00 (0.99, 1.02) 0.76
Triglycerides 1.0 mmol/L (61.5) 1 1.07 (0.91, 1.26) 1.08 (0.92, 1.28) 1.21 (1.01, 1.45) 1.02 (0.85, 1.22) 1.04 (0.95, 1.13) 0.37
HDL cholesterol 1.5 mmol/L (61.2) 1 1.05 (0.97, 1.14) 1.02 (0.94, 1.11) 1.07 (0.98, 1.17) 1.05 (0.96, 1.15) 1.04 (1.00, 1.09) 0.06
LDL cholesterol 2.4 mmol/L (61.4) 1 1.08 (0.96, 1.21) 1.06 (0.94, 1.20) 1.14 (1.00, 1.29) 1.15 (1.01, 1.31) 1.05 (0.99, 1.12) 0.10
Total cholesterol 4.5 mmol/L (61.2) 1 1.06 (0.99, 1.15) 1.05 (0.97, 1.13) 1.12 (1.03, 1.22) 1.11 (1.02, 1.20) 1.05 (1.01, 1.09) 0.01
Systolic blood
pressure*
104.8 mmHg (68.1) 0 22.16
(25.44, 1.11)
21.86
(25.13, 1.42)
20.34
(23.94, 3.25)
21.50
(25.11, 2.11)
20.51
(22.23, 1.21)
0.56
Diastolic blood
pressure*
66.5 mmHg (66.4) 0 0.58
(21.93, 3.09)
0.11
(22.40, 2.62)
2.07
(20.68, 4.82)
0.98
(21.79, 3.74)
0.52
(20.80, 1.84)
0.44
Waist
circumference*
79.4 cm (65.3) 0 1.03
(20.78, 2.85)
1.04
(20.78, 2.86)
1.18
(20.82, 3.17)
2.00
(20.01, 4.00)
0.78
(20.17, 1.74)
0.11
BMI 21.9 kg/m2 (61.2) 1 1.00 (0.95, 1.05) 1.02 (0.96, 1.07) 1.04 (0.98, 1.10) 1.02 (0.96, 1.08) 1.01 (0.98, 1.04) 0.52
HOMA-IR 1.2 (61.6) 1 1.14 (0.95, 1.36) 1.23 (1.03, 1.46) 1.33 (1.10, 1.61) 1.13 (0.93, 1.37) 1.08 (0.99, 1.19) 0.10
Insulin 41.1 mmol/L (61.5) 1 1.21 (1.03, 1.43) 1.22 (1.03, 1.44) 1.29 (1.08, 1.55) 1.17 (0.97, 1.40) 1.08 (0.99, 1.19) 0.07
Leptin 13.4 ug/L (62.1) 1 1.04 (0.79, 1.38) 1.19 (0.90, 1.58) 1.42 (1.05, 1.94) 1.40 (1.03, 1.91) 1.21 (1.05, 1.40) 0.01
Shown are the mean differences in the outcome variables waist circumference and systolic and diastolic blood pressure (indicated by*) and mean ratio for all other log
transformed outcome variables. The table includes figures from analyses of quintiles of GI, and from analyses of the data using GI as continuous variable (ratio or
difference per 10U GI increment)1.
1Adjustment for potential confounding by multiple linear regression including energy intake, pre-pregnancy BMI (kg/m2), height (cm), smoking, education, and
offspring leisure activity. The p-value is the result of analyses of the data using GI as continuous variable (n = 234). GI quintiles were determined from the original data
files including 894 women.
doi:10.1371/journal.pone.0064887.t003
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the HAPO study suggested that mild elevations of maternal
plasma glucose levels may impact on birth weight as well as risk of
maternal and fetal pregnancy complications even at a level below
conventional diagnostic GDM plasma glucose cut off levels [33].
In the present study, also after exclusion of the 11 GDM cases, the
data revealed associations between dietary GI in pregnancy and
distinct offspring MS markers. Given the known influence of GI on
plasma glucose levels even in non-diabetic pregnant women (10),
we speculate that subtle elevations of plasma glucose in pregnant
women may be a mediator of the programming effect of GI in
pregnancy.
The associations observed between maternal GI and offspring
levels of HOMA-IR, leptin and insulin did not differ significantly
between male and female offspring (p.0.05). Notably, however,
when restricting the analyses to either sex, the associations for
leptin and insulin persisted in females but not in males. This
finding may reflect a lower participation rate among the latter or
sex-specific mechanisms in the fetal programming of metabolic
traits. Recently, in the same birth cohort, we detected obesogenic
effects in female but not in male offspring as a result of fetal
exposure to perfluorooctanoate [34]. Our findings are in line with
a recent study on data from the great Chinese famine, where
exposure to severe undernutrition in fetal life was associated with
higher risk of MS in adult women but not in men [35] and with
another study on data from the Dutch famine study, where
maternal malnutrition during early gestation was associated with
obesity only in women [36]. Sexual dimorphism in developmental
programming may be explained by the sexually dimorphic
embryo-derived tissue of the placenta which plays a significant
role in determing fetal size, nutrition, morbidity and survival [37].
During recent years, evidence has emerged from rodent and
human studies that the growth of the placenta and gene expression
as well as DNA methylation differ between the sexes and
furthermore that the sexes respond differently to environmental
insults [37–39]. Differences in response to quality or composition
of the maternal diet on the sex-dependent placental gene
expression have been observed as well, providing insight in
different sensitivity of male and female fetuses to the maternal diet.
Thus the female placenta seems to be more adaptive to changes in
maternal diet compared to the male placenta [40]. Furthermore, it
has been shown that the maternal diet composition influences the
cortisol level in the mother [41–43] and, in addition, changes the
gene expression and the activity of the HPA axis, which regulate
the glucocorticoid production, differently in male and female
fetuses and offspring [37,44]. Among humans, higher maternal
cortisol was associated with marginally higher Fat Mass Index
(FMI) in 5 year old girls, but marginally lower FMI in boys [45],
indicating that diet-dependent maternal cortisol levels may
influence the offspring with long-term consequences.
Our data indicates that GI during pregnancy has stronger
influence on the offspring’s metabolic profile than GL. In previous
studies investigating the associations between dietary GI and GL
on biomarkers for metabolic disease in adults, the associations
were not consistent between GI and GL [46–48]. Recent meta-
analyses have reported statistically significant associations between
GI or GL and chronic diseases including cardiovascular disease
and type 2 diabetes and came to different conclusions when
addressing the question of whether GI or GL had the most
powerful effect on development of disease [47,49]. Interestingly,
the associations between GI and GL on one hand and adult
disease on the other in general have been reported to be stronger
in women than in men [46,47], which may further support our
sex-dependent findings in the offspring.
Table 4. MS markers in male offspring dependent on their mothers’ dietary GI in 2nd trimester.
Ratio or difference* (95% CI)
GI quintile
1 Gi quintile 2 GI quintile 3 Gi quintile 4 GI quintile 5 GI continuous
p-
value
Mean 6 SD 60.8+3.6 67.4+1.3 71.1+1.0 74.5+1.1 80.0+2.7 70.666.4
Fasting glucose 5.1 mmol/L (61.1) 1 1.00 (0.96, 1.04) 1.02 (0.98, 1.06) 1.03 (0.99, 1.07) 1.03 (0.98, 1.07) 1.02 (1.00, 1.04) 0.06
Triglycerides 0.8 mmol/L (61.5) 1 0.99 (0.80, 1.21) 1.14 (0.94, 1.38) 1.11 (0.92, 1.35) 1.09 (0.87, 1.35) 1.06 (0.96, 1.17) 0.26
HDL cholesterol 1.3 mmol/L (61.2) 1 1.04 (0.93, 1.17) 1.07 (0.96, 1.19) 1.02 (0.92, 1.14) 0.99 (0.88, 1.12) 1.01 (0.95, 1.06) 0.82
LDL cholesterol 2.3 mmol/L (61.3) 1 1.02 (0.88, 1.18) 1.08 (0.94, 1.24) 1.06 (0.93, 1.21) 0.96 (0.83, 1.12) 0.99 (0.93, 1.07) 0.87
Total cholesterol 4.0 mmol/L (61.2) 1 1.01 (0.92, 1.11) 1.08 (0.99, 1.17) 1.04 (0.96, 1.14) 0.97 (0.88, 1.07) 1.00 (0.95, 1.04) 0.96
Systolic blood
pressure*
117.5 mmHg (69.3) 0 23.59
(28.52, 1.33)
21.92
(26.50, 2.66)
21.01
(25.63, 3.61)
24.00
(29.23, 1.23)
21.14
(23.50, 1.21)
0.34
Diastolic blood
pressure*
64.5 mmHg (67.0) 0 21.28
(24.87, 2.30)
20.13
(23.47, 3.21)
20.94
(24.31, 2.43)
22.26
(26.08, 1.55)
20.21
(21.92, 1.51)
0.81
Waist
circumference*
84.0 cm (65.7) 0 21.55
(23.73, 0.63)
21.20
(23.22, 0.83)
20.52
(22.56, 1.52)
20.81
(23.12, 1.50)
20.19
(21.23, 0.85)
0.72
BMI 22.8 kg/m2 (62.9) 1 0.98 (0.92, 1.04) 1.02 (0.96, 1.08) 1.02 (0.96, 1.08) 1.00 (0.93, 1.07) 1.02 (0.99, 1.05) 0.32
HOMA-IR 1.2 (61.6) 1 0.89 (0.71, 1.11) 1.06 (0.86, 1.30) 1.23 (1.00, 1.52) 1.05 (0.83, 1.32) 1.09 (0.98, 1.22) 0.10
Insulin 37.2 pmol/L (61.5) 1 0.88 (0.71, 1.10) 1.04 (0.85, 1.27) 1.24 (1.01, 1.52) 1.01 (0.80, 1.27) 1.08 (0.97, 1.20) 0.14
Leptin 2.3 ug/L (62.7) 1 0.78 (0.46, 1.31) 1.20 (0.73, 1.96) 1.20 (0.74, 1.97) 0.91 (0.52, 1.59) 1.14 (0.88, 1.46) 0.31
Shown are the mean differences in the outcome variables waist circumference and systolic and diastolic blood pressure (indicated by*) and mean ratio for all other log
transformed outcome variables. The table includes figures from analyses of quintiles of GI, and from analyses of the data using GI as continuous variable (ratio or
difference per 10U GI increment)1.
1Adjustment for potential confounding by multiple linear regression including energy intake, pre-pregnancy BMI (kg/m2), height (cm), smoking, education, and
offspring leisure activity. The p-value is the result of analyses of the data using GI as continuous variable (n = 152). GI quintiles were determined from the original data
files including 894 women.
doi:10.1371/journal.pone.0064887.t004
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A limitation of the study is the use of biomarkers for MS and not
MS per se in the offspring, as none of the young people had
developed overt MS at the time of follow-up. The study had
several strengths. Information on maternal diet was provided
prospectively with no knowledge about offspring conditions,
physical activity or body proportions, and the study had a long
follow-up period. We could not identify any participation bias with
regards to the exposure levels (cf. table 1).
In conclusion, ourdata suggests that dietaryGI in second trimester
of pregnancymay be a determinant ofHOMA-IR and plasma levels
of insulin, leptin and cholesterol in the adult offspring.GI andGLdid
not seem topredictmarkers ofMS inmales,whereas bothGI andGL
were associated with specific markers of MS among the females. We
speculate that the programming effect(s) of maternal dietary GI in
pregnancy may be mediated via subtle elevations of plasma glucose
levels within the non-diabetic range. This remains to be addressed in
future studies.
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